Scroll Top

Healthcare Public Relations

Updated September 2026 · Written and maintained by the Progression Agency strategy team

Healthcare communications operates under constraints that do not apply elsewhere: claims attract substantiation expectations, patient privacy law governs storytelling, specialist journalists read the underlying evidence, and review involves legal, clinical and regulatory opinion rather than a marketing sign-off. This answers the questions organizations in health ask most often — about claims, consent, audiences, bad news and measurement.

The short answerA statement written for patients is read by clinicians, payers and regulators too, and it has to survive all three readings. That is the single structural difference from ordinary communications work — and it is why the safest ground is describing what was measured rather than characterising what it means. Take qualified regulatory advice on any specific claim; nothing here substitutes for it.

Progression Agency is based in New York City and works with clients across the United States. This page is general communications guidance and is not legal, regulatory or clinical advice. Requirements differ by organization type, product classification and jurisdiction — take qualified advice on your own situation before making any claim or publishing any patient story.

Healthcare communications in short
Overstatement costs more here than in any other sector, because the audience most likely to notice is also the one whose trust the organization depends on.

What is healthcare public relations?

Communications work for organizations in health — providers, systems, medical device and life science companies, digital health and payers — conducted under regulatory constraints that do not apply to most other sectors.

The constraints are the defining feature. What can be claimed, who can be named, and what counts as promotion rather than information are all governed in ways that shape every piece of work.

How a healthcare communication actually gets out
Steps four and five are where timelines are set. Planning around them is the difference between a workable program and constant late rewrites.

How is healthcare PR different from ordinary PR?

Regulated claims, patient privacy, clinical accuracy, and a press corps that will check what you say against the evidence.

A claim that would be ordinary marketing language in another sector can be a regulatory problem here, which is why review processes exist and why they take time.

What makes healthcare communications different
FactorIn most sectorsIn healthcare
Claims about resultsMarketing languageSubstantiation expected, sometimes required
Naming individualsRoutine with consentPatient privacy law applies
Clinical accuracyRarely scrutinisedChecked by specialist press
Review processMarketing sign-offFrequently legal, clinical and regulatory
SpeedHoursDays, and planning around that is the job
SpokespeopleAnybody briefedClinical credibility matters
Bad newsReputationalFrequently also regulatory
AudiencesCustomersPatients, clinicians, payers, regulators, investors

The audiences row is the one that changes strategy most. A statement written for patients is read by clinicians and regulators too, and it has to survive all three readings.

Who are the audiences and how do they differ?

Patients and carers, clinicians, payers and purchasers, regulators, investors and staff — and each judges the same statement by a different standard.

Writing for one audience and hoping the others do not read it is not available in this sector; everything is public and everything is checked.

Patients and carers — Audience. Plain language, honest uncertainty..
Clinicians — Audience. Judge on evidence quality..
Payers — Audience. Outcomes and cost, with evidence..
Regulators — Audience. They read what you publish..
Investors — Audience. Disclosure rules constrain timing..
Staff — Audience. Your most credible external voice..

Patients and carers

Need plain language, honest uncertainty, and no implied promise about individual outcomes.

Clinicians

Judge on evidence quality. Overstatement destroys credibility with this audience faster than with any other.

Payers and purchasers

Care about outcomes, cost and evidence of both, rather than about features.

Regulators

Read what you publish. Nothing is off the record, and consistency between what you tell them and what you say publicly matters.

Investors

In commercial health organizations, subject to their own disclosure rules, which constrain timing as well as content.

Staff and clinicians internally

Frequently the most credible external voice you have, and the most damaging if they are not informed.

What can and cannot be claimed?

That depends on what the organization is and what is being described — and it is a question for qualified regulatory and legal advice on the specific claim, not a general rule.

What is generally true is that claims about clinical outcomes attract scrutiny proportionate to how specific they are, and that the safest ground is describing what was measured rather than characterising what it means.

Describe the evidence, not the conclusion

Saying what a study measured and in whom is more defensible than summarizing what it proves.

Avoid implied individual promises

Population-level findings do not translate to what any one person should expect, and language that blurs that is a real risk.

Be careful with comparatives

Comparative claims typically attract a higher substantiation burden than descriptive ones.

Get review before drafting is finished

Late regulatory review produces rewrites; early involvement produces workable drafts.

Keep the record

What was approved, by whom, on what date. It matters more here than in most sectors.

Take advice on your specific situation

Rules differ by organization type, product class and jurisdiction, and general guidance is not a substitute.

How does patient privacy affect storytelling?

Patient stories are among the most effective communications available and among the most tightly constrained — consent has to be specific, informed, documented and revocable.

The shortcut of using a story without proper consent is a legal exposure rather than a communications risk, and it is one of the few mistakes in this field that cannot be repaired.

Using patient stories responsibly
RequirementWhat it meansWhy it matters
Specific consentFor this use, not consent in generalBroad consent frequently is not valid
Informed consentThey understand where it will appearIncluding that it may be reshared
DocumentedWritten, dated, retainedThe record is what protects everybody
RevocableThey can withdraw itAnd you need a process for that
No pressureEspecially where care is involvedThe relationship is unequal
Accurate portrayalTheir experience, not your messageEditing that changes meaning is a problem
No implied typicalityOne person’s outcome is not a claimThis is where stories become claims
Consider identifiabilityDetails can identify without a nameComposite details still identify

The typicality row is where good intentions most often create a regulatory problem: a true story presented in a way that suggests a typical result functions as an outcome claim.

What does a healthcare PR program usually include?

Media relations with general and trade press, thought leadership from credible clinicians, data and study communications, issues management, and internal communications.

The proportions vary enormously by organization type. A hospital system, a device manufacturer and a digital health company have almost nothing in common in what they actually need.

Where healthcare communications effort typically goes
Illustrative only. The point is the second row: review is a real share of the work rather than an overhead on it.

How do you work with specialist health journalists?

By being accurate, being available, and accepting that they will read the underlying evidence rather than the press release.

Health and trade journalists in this field are frequently more expert than the person briefing them, which makes overstatement counterproductive in a way it is not elsewhere.

Send the evidence, not just the summary

Journalists who can read the study will, and withholding it reads as evasion.

Be honest about limitations

Sample size, population, follow-up period. Volunteering these builds credibility that survives the next story.

Offer credible spokespeople

Clinicians who can answer detailed questions rather than communications staff reading approved language.

Respect embargoes and deadlines

Both are taken seriously and breaking either has lasting consequences with a small press corps.

Do not oversell early-stage work

Preliminary findings described as breakthroughs damage credibility for years.

Correct errors quickly and privately first

Public correction demands rarely improve the relationship or the coverage.

What are the common mistakes?

Overstating evidence, using patient stories without proper consent, treating regulatory review as an obstacle, and being slow when something goes wrong.

The first three are avoidable with process. The fourth is avoidable with preparation, and it is the one that does the most damage when it happens.

Where healthcare communications risk actually sits
The top-left entries are rare and severe; the middle cluster is common and damaging. Process addresses the first group, and training addresses the second.
Overstating evidence — Mistake. Costs most with clinicians..
Consent shortcuts — Mistake. Legal exposure, not just risk..
Implying typical outcomes — Mistake. A story becomes a claim..
Review treated as an obstacle — Mistake. Produces rewrites, not drafts..
Slow on bad news — Mistake. Duties have deadlines..
Staff told last — Mistake. They are asked first..

How should healthcare organizations handle bad news?

Rapidly, factually, with patient safety addressed first and regulatory obligations met — and with communications and legal working together rather than sequentially.

Health incidents frequently carry mandatory reporting duties with fixed deadlines, which constrains the communications timeline in ways that must be understood in advance.

What is the role of internal communications?

Central. Clinical and support staff are the most credible voices about an organization and the first people patients ask.

Staff who learn about something from the news become an uncontrolled and understandably unhappy channel, which is a communications failure with clinical consequences in this sector.

How is healthcare PR measured?

Reach in the publications the relevant audiences actually read, share of voice on the issues that matter, and the specific outcomes the program exists to support.

Coverage volume alone is a poor measure here, because one trade article read by the right two hundred people can matter more than a national mention.

Measuring healthcare communications
MeasureWhy it is usefulCaution
Coverage in target publicationsReaches decision-makersVolume alone means little
Quality of message inclusionDid the point survive?Requires actual reading
Share of voice on key issuesPosition in the debateNeeds a defined issue set
Clinician engagementThe hardest audience to reachSlow to move
Referral or enquiry volumeCommercial outcomeAttribution is difficult
Recruitment interestFrequently a real objectiveLagging indicator
Investor and analyst sentimentWhere applicableSubject to disclosure rules
Absence of regulatory issuesA genuine outcomeInvisible when it works

The last row is the one nobody reports and everybody values: a program that has produced no regulatory problems has achieved something real, and no dashboard shows it.

Should you hire a healthcare specialist or a generalist agency?

A specialist where regulated claims, clinical evidence or trade press are central. A generalist can work where the communications are essentially ordinary and the sector is incidental.

The test is whether the work will routinely require judgement about what can be said, because that judgement is what specialist experience actually buys.

What should you ask a healthcare PR agency?

How they handle regulatory review, who on the team has clinical or regulatory background, how they handle patient consent, and what they would refuse to say.

The consent question is the most diagnostic. An agency without a documented process for patient stories has not done much healthcare work.

How do you handle review? — Ask. Early or late?.
Who has clinical background? — Ask. On the actual team..
What is your consent process? — Ask. The most diagnostic question..
What would you refuse to say? — Ask. Judgement, not compliance..
Which trade press do you know? — Ask. Names, not categories..
How do you measure it? — Ask. Not coverage volume alone..

How does healthcare PR differ across organization types?

A hospital system, a device manufacturer, a digital health company and a payer face different regulators, different audiences and different claim rules — and almost nothing transfers between them unexamined.

This is the main reason sector experience matters more here than in most fields: the constraints are specific rather than general.

How the work differs by organization type
Organization typePrimary audiencesDominant constraint
Hospital or health systemPatients, staff, local communityPrivacy and incident duties
Medical device companyClinicians, payers, regulatorsClaims and classification rules
Pharmaceutical or biotechClinicians, investors, regulatorsPromotion rules and disclosure
Digital health companyClinicians, payers, investorsEvidence expectations, still forming
Payer or insurerMembers, providers, regulatorsPlain language and accuracy duties
Clinical research organizationSponsors, sites, investigatorsConfidentiality
Nonprofit health organizationDonors, patients, policymakersAccuracy and advocacy limits
Health technology vendorProvider buyersSubstantiating operational claims

The digital health row is the most volatile: evidence expectations for that category are still forming, and what passed without challenge a few years ago increasingly does not.

What should you prepare before you need it?

A consent process and template, a named clinical reviewer, a regulatory review path with an agreed turnaround, holding statements, and a trained clinical spokesperson.

Every item on that list saves days at the moment it is needed, and none of it can be built while something is going wrong.

How do you brief a clinician to speak publicly?

By agreeing what is being claimed before any interview, checking that they are comfortable with the limits of the evidence, and preparing the questions they will be asked about it.

Clinicians are frequently more cautious than the communications team and more precise than the marketing language. Both of those are assets rather than obstacles.

What do you do when the evidence is weaker than the marketing wants it to be?

You describe what the evidence actually supports and change the marketing, rather than describing the evidence in language it does not support.

This is the recurring tension in healthcare communications, and it is the one where an agency or internal team earns its position by being willing to lose the argument in the right direction.

When evidence and messaging pull apart
SituationWeak responseBetter response
Preliminary data, strong hopesCall it a breakthroughSay what stage it is at
Small study, promising resultImply generalityState the population and size
Positive on a secondary endpointLead with itReport what was pre-specified
Real-world data, no controlClaim causationDescribe the association
Competitor makes a bigger claimMatch itPoint at your own evidence
Sales wants a comparative claimMake it softlySubstantiate it or drop it
A striking patient outcomeFeature it as typicalPresent it as one case
Regulatory review says noReword until it passesAsk what would be supportable

The final row is the one that separates teams that work well with regulatory review from those in permanent conflict with it: asking what would be supportable produces publishable material, and rewording until something slips through produces a problem later.

Communicating in a regulated environment?

We work with clients across the United States, including in regulated sectors, and we build review into the process rather than treating it as an obstacle at the end — because in health communications the review is the work.

Talk to Progression Agency

Video: communications practice

A general library on marketing and communications practice. The healthcare material is written out in full above.

Getting found in search

AI, AEO and what is changing

Paid media and lead generation

Websites and design

Choosing and working with an agency

Social, content and brand

By industry and by situation

Frequently asked questions

How does life sciences public relations differ from healthcare PR generally?
Investor disclosure obligations, clinical trial communication rules and a technical press corps make it tighter still. Life sciences public relations frequently has securities considerations layered on top of the clinical and regulatory ones.
What is healthcare public relations?
Communications work for health organizations — providers, systems, device and life science companies, digital health and payers — conducted under regulatory constraints that do not apply to most other sectors.
How is it different from ordinary PR?
Claims attract substantiation expectations, patient privacy law governs storytelling, specialist journalists read the underlying evidence, and review involves legal, clinical and regulatory opinion rather than a marketing sign-off.
Who are the audiences?
Patients and carers, clinicians, payers and purchasers, regulators, investors where applicable, and staff — each judging the same statement by a different standard.
Can I write for one audience and ignore the others?
No. Everything is public and everything is checked. A statement written for patients is read by clinicians and regulators too.
What can we claim about clinical outcomes?
That depends on organization type, product classification and jurisdiction, and it is a question for qualified regulatory advice on the specific claim rather than a general rule.
What is the safest general approach to claims?
Describe what was measured and in whom, rather than characterising what it means. Evidence descriptions are more defensible than conclusions.
Are comparative claims riskier?
They typically attract a higher substantiation burden than descriptive ones, which is worth knowing before a draft is built around one.
When should regulatory review happen?
Early, while drafting. Late review produces rewrites; early involvement produces drafts that can actually be published.
Can we use patient stories?
Yes, with specific, informed, documented and revocable consent. They are among the most effective communications available and among the most tightly constrained.
Is general consent enough?
Frequently not. Consent should be specific to this use, and the person should understand where it will appear and that it may be reshared.
Can somebody withdraw consent?
Yes, and you need a process for handling that — including removing material already published where it is possible to do so.
What is the commonest mistake with patient stories?
Presenting a true story in a way that implies a typical result. That turns a story into an outcome claim, which is a regulatory matter rather than an editorial one.
Does removing the name make a story anonymous?
Not necessarily. Combinations of details can identify somebody without a name, which is why identifiability should be assessed rather than assumed.
What does a healthcare PR program include?
Media and trade relations, thought leadership from credible clinicians, data and study communications, issues and incident readiness, and internal communications.
How do I work with specialist health journalists?
Be accurate, be available, and send the evidence rather than only the summary. They will read the underlying study, and withholding it reads as evasion.
Should we volunteer study limitations?
Yes. Sample size, population and follow-up period volunteered up front build credibility that survives the next story.
Why is overstatement worse in this sector?
Because the audience most likely to notice — clinicians and specialist press — is also the audience whose trust the organization depends on.
Who should the spokesperson be?
Somebody with clinical credibility who can answer detailed questions, rather than communications staff reading approved language.
How should bad news be handled?
Rapidly and factually, with patient safety addressed first and regulatory duties met — and with legal and communications working together rather than sequentially.
Do reporting duties affect the timeline?
Frequently yes. Health incidents often carry mandatory reporting duties with fixed deadlines, which constrain when and what you can say publicly.
Why does internal communications matter so much here?
Because clinical and support staff are the most credible voices about an organization and the first people patients ask. Staff who learn from the news become an uncontrolled channel.
How is healthcare PR measured?
Coverage in the publications the relevant audiences actually read, quality of message inclusion, share of voice on defined issues, and the specific outcomes the program supports.
Is coverage volume a good measure?
No. One trade article read by the right two hundred people can matter more than a national mention, which volume counting cannot distinguish.
What outcome never appears in reporting?
The absence of regulatory problems. A program that has produced none has achieved something real, and no dashboard shows it.
Do we need a healthcare specialist agency?
Where regulated claims, clinical evidence or trade press are central, yes. Where the communications are essentially ordinary and the sector is incidental, a generalist can work.
What should I ask a healthcare PR agency?
How they handle regulatory review, who on the team has clinical or regulatory background, what their patient consent process is, and what they would refuse to say.
Which of those questions is most diagnostic?
The consent process. An agency without a documented process for patient stories has not done much healthcare work.
Is this page a substitute for regulatory advice?
No. Requirements differ by organization type, product classification and jurisdiction. Take qualified advice on your own situation before making any claim.

Sources and further reading

  1. Google Search Essentials — SEO starter guide
  2. Google: creating helpful, reliable, people-first content
  3. Google: intro to structured data
  4. Google: LocalBusiness structured data
  5. Google: FAQPage structured data
  6. Google: Article structured data
  7. Google: Product structured data
  8. Google: title links in search results
  9. Google: control your snippets
  10. Google: robots.txt introduction
  11. Google: sitemaps overview
  12. Google: consolidate duplicate URLs
  13. Google: redirects and Search
  14. Google: JavaScript SEO basics
  15. Google: multi-regional and multilingual sites
  16. Google Search Central Blog
  17. Google: get started with Search Console
  18. Google: how local search results are determined
  19. Google Business Profile: prohibited and restricted content
  20. Google Business Profile: address and service area guidelines
  21. Google Business Profile: review policy
  22. Google Business Profile: add or edit categories
  23. Google Ads: location targeting settings
  24. Google Ads: about negative keywords
  25. Google Ads: about Quality Score
  26. Google Ads: importing offline conversions
  27. Google Ads: about Smart Bidding
  28. Google Ads: about Performance Max
  29. Google Local Services Ads: eligibility and screening
  30. Google Ads: keyword match types
  31. Google Analytics 4: about conversions
  32. Google Analytics 4: attribution models
  33. US Census Bureau QuickFacts: New Jersey
  34. US Census Bureau: American Community Survey
  35. US Census: Statistics of US Businesses
  36. Bureau of Labor Statistics: New Jersey data
  37. BLS: Occupational Employment and Wage Statistics
  38. NJ Department of Labor: labor market information
  39. New Jersey Business Action Center
  40. US Small Business Administration: New Jersey district
  41. USA.gov: business resources
  42. web.dev: Core Web Vitals explained
  43. web.dev: Largest Contentful Paint
  44. web.dev: Cumulative Layout Shift
  45. web.dev: Interaction to Next Paint
  46. Google PageSpeed Insights
  47. Google Rich Results Test
  48. Google Search Console
  49. W3C Markup Validation Service
  50. Schema.org: LocalBusiness type
  51. Schema.org: Service type
  52. Schema.org: FAQPage type
  53. Schema.org: HowTo type
  54. W3C: WCAG 2.2 quick reference
  55. FTC: CAN-SPAM Act compliance guide
  56. FCC: telemarketing and robocall rules (TCPA)
  57. FTC endorsement guides — reviews and testimonials
  58. FTC: rule on consumer reviews and testimonials
  59. HHS: HIPAA guidance on online tracking technologies
  60. New Jersey Courts: attorney advertising guidelines
  61. New Jersey DCA: construction codes and permits
  62. New Jersey Home Improvement Contractor registration
  63. New Jersey Division of Consumer Affairs
  64. TikTok for Business
  65. TikTok Creative Center
  66. TikTok Ads Help Center
  67. TikTok Community Guidelines
  68. TikTok Terms of Service
  69. TikTok Privacy Policy
  70. TikTok Safety Center
  71. TikTok Transparency Center
  72. TikTok Creator Portal
  73. TikTok Newsroom
  74. TikTok for Developers
  75. TikTok advertising solutions
  76. TikTok Creator Marketplace
  77. TikTok Business Center
  78. TikTok for Business blog
  79. TikTok Creative Center: top ads
  80. TikTok Branded Content policy
  81. TikTok Shop for sellers
  82. Instagram for Business
  83. Instagram for Creators
  84. Instagram Help Center
  85. About Instagram
  86. Meta Business Suite
  87. Meta Business Help Center
  88. Meta Transparency Center
  89. About Meta
  90. Meta: Instagram platform docs
  91. YouTube Creators
  92. YouTube Official Blog
  93. YouTube Shorts help
  94. How YouTube Works
  95. YouTube Studio
  96. LinkedIn Marketing Solutions
  97. LinkedIn Help
  98. Pinterest Business
  99. Pinterest Business Help
  100. Snapchat for Business
  101. X for Business
  102. Reddit communities
  103. Reddit for Business Help
  104. ASCAP
  105. BMI
  106. SESAC
  107. Global Music Rights
  108. PRS for Music (UK)
  109. PPL (UK)
  110. SOCAN (Canada)
  111. APRA AMCOS (Australia)
  112. GEMA (Germany)
  113. SACEM (France)
  114. SIAE (Italy)
  115. JASRAC (Japan)
  116. IFPI
  117. RIAA
  118. National Music Publishers Association
  119. Harry Fox Agency
  120. SoundExchange
  121. Music Reports
  122. Epidemic Sound
  123. Artlist
  124. Soundstripe
  125. PremiumBeat
  126. AudioJungle
  127. Free Music Archive
  128. Creative Commons
  129. Incompetech
  130. FTC: advertising and marketing
  131. FTC: disclosures 101
  132. FTC: endorsement guides
  133. FTC: consumer reviews rule
  134. FTC: advertising FAQs
  135. US Copyright Office
  136. US Copyright Office: DMCA
  137. US Copyright Office: music FAQ
  138. US Copyright Office: fair use FAQ
  139. USPTO: trademarks
  140. UK Advertising Standards Authority
  141. ACCC (Australia)
  142. Competition Bureau Canada
  143. GDPR overview
  144. California Consumer Privacy Act
  145. COPPA
  146. FTC: children’s privacy
  147. W3C Web Accessibility Initiative
  148. W3C: WCAG
  149. W3C: captions
  150. W3C: making audio and video accessible
  151. ADA.gov
  152. WebAIM
  153. Epilepsy Foundation
  154. Pew Research: internet and technology
  155. DataReportal
  156. US Census Bureau
  157. US Bureau of Labor Statistics
  158. Interactive Advertising Bureau
  159. Think with Google
  160. Google Trends
  161. Nielsen insights
  162. Schema.org: VideoObject
  163. Schema.org: SocialMediaPosting
  164. Schema.org: MusicRecording
  165. Schema.org: HowTo
  166. Schema.org: FAQPage
  167. Schema.org: Organization
  168. Google: video best practices
  169. Google: video structured data
  170. CapCut
  171. Adobe Premiere Rush
  172. DaVinci Resolve
  173. Canva
  174. Descript
  175. VEED
  176. Kapwing
  177. Otter.ai
  178. Later
  179. Buffer
  180. Hootsuite
  181. Sprout Social
  182. Google Analytics
  183. Google Search Console
  184. Google Analytics developer docs
  185. GA4: events and conversions
  186. Matomo
  187. Plausible Analytics
  188. Similarweb
  189. UK Information Commissioner’s Office
  190. Office of the Privacy Commissioner of Canada
  191. Australian OAIC
  192. European Data Protection Board
  193. EU data protection
  194. EU Digital Services Act
  195. Ofcom
  196. FCC
  197. AIGA
  198. Nielsen Norman Group
  199. Smashing Magazine
  200. web.dev
  201. MDN: web media
  202. MDN: the video element
  203. ISO 21001 (reference)
  204. Buma/Stemra (Netherlands)
  205. STIM (Sweden)
  206. Teosto (Finland)
  207. Koda (Denmark)
  208. TONO (Norway)
  209. IMRO (Ireland)
  210. SGAE (Spain)
  211. ZAiKS (Poland)
  212. KOMCA (South Korea)
  213. MCSC (China)
  214. CISAC
  215. World Intellectual Property Organization
  216. TikTok: creating videos
  217. TikTok: exploring videos
  218. TikTok: privacy settings
  219. TikTok: growing your audience
  220. TikTok Creator Academy
  221. TikTok Effect House
  222. TikTok for small business
  223. Instagram: Reels help
  224. YouTube: Shorts best practice
  225. How YouTube recommends
  226. Pinterest Predicts
  227. Snapchat for Business
  228. Hootsuite blog
  229. Social Media Examiner
  230. Marketing Week
  231. Adweek

Get a free marketing proposal

Tell us what you are trying to grow and we will come back with a plan, not a pitch deck. Same-day reply on weekdays.

Our website uses cookies from third party services to improve your browsing experience. Read more about this and how you can control cookies by clicking "Privacy Preferences".
Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.
Privacy Policy
You have read and agreed to our privacy policy
Required